Stay updated on Dapagliflozin Sodium Excretion Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin Sodium Excretion Clinical Trial page.

Latest updates to the Dapagliflozin Sodium Excretion Clinical Trial page
- Check2 days agoChange DetectedClinicalTrials.gov page footer revision version was updated from v3.5.0 to v3.5.3.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedRevision: v3.5.0 added and Revision: v3.4.3 removed; this appears to be a non-content site update with no impact on study details.SummaryDifference0.1%

- Check52 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no content, data, or functional changes are indicated. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check81 days agoChange DetectedThe page shows a new site revision label (v3.4.1) and removal of the previous v3.4.0; no study details, enrollment, or trial information appear to be affected—To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check96 days agoChange DetectedMinor UI and metadata updates include glossary show/hide controls, capitalization tweaks on labels, and an updated revision indicator (v3.4.0), with no changes to core study content, outcomes, or eligibility details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Dapagliflozin Sodium Excretion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Sodium Excretion Clinical Trial page.